Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis

As an adjuvant immunotherapy, cytokine-induced killer cells (CIKs) infusion has been demonstrated to exert potent effectiveness in several types of cancer patients who received curative treatment. However, controversy exists regarding whether nasopharyngeal carcinoma (NPC) patients can benefit from...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jing-Jing, Zhou, Shu, Chen, Chang-Long, Zhang, Hong-Xia, Zhou, Zi-Qi, Wu, Zheng-Rong, Liu, Yuan, Pan, Qiu-Zhong, Zhu, Qian, Tang, Yan, Xia, Jian-Chuan, Weng, De-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277608/
https://www.ncbi.nlm.nih.gov/pubmed/30519321
http://dx.doi.org/10.7150/jca.25790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277608/
https://www.ncbi.nlm.nih.gov/pubmed/30519321
http://dx.doi.org/10.7150/jca.25790

Ejemplares similares